RC
BIO icon

Roubaix Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Roubaix Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,112
Closed -$2.27M – 52
2025
Q3 		$2.27M Buy
+8,112
New +$2.21M 1.06% 44
2025
Q1 		– Sell
-11,303
Closed -$3.71M – 55
2024
Q4 		$3.71M Buy
+11,303
New +$3.84M 1.78% 31
2024
Q3 		– Sell
-8,996
Closed -$2.46M – 51
2024
Q2 		$2.46M Sell
8,996
-6,747
-43% -$1.96M 1.55% 34
2024
Q1 		$5.45M Buy
15,743
+3,194
+25% +$1.05M 3.44% 8
2023
Q4 		$4.05M Buy
+12,549
New +$3.93M 2.84% 13
2019
Q4 		– Sell
-7,496
Closed -$2.49M – 38
2019
Q3 		$2.49M Sell
7,496
-11,789
-61% -$3.85M 2.27% 22
2019
Q2 		$6.03M Buy
+19,285
New +$5.77M 5.03% 3

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return